Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

GENERAL COUNSEL

COO & CFO

CHIEF EXECUTIVE OFFICER

CHIEF SCIENTIFIC OFFICER

CHRO

CHIEF COMMERCIAL OFFICER

CHIEF MEDICAL OFFICER

SVP AND HEAD OF RESEARCH

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and iron-restricted anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-09	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	sold	Premium	Premium	Premium	GENERAL COUNSEL
2024-02-16	Premium	sold	Premium	Premium	Premium	COO & CFO
2024-02-16	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-16	Premium	sold	Premium	Premium	Premium	CHIEF SCIENTIFIC OFFICER
2024-02-16	Premium	sold	Premium	Premium	Premium	CHRO
2024-02-12	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-12	Premium	acquired	Premium	Premium	Premium	CHIEF COMMERCIAL OFFICER
2024-02-12	Premium	acquired	Premium	Premium	Premium	COO & CFO
2024-02-12	Premium	acquired	Premium	Premium	Premium	CHRO
2024-02-12	Premium	acquired	Premium	Premium	Premium	GENERAL COUNSEL
2024-02-12	Premium	acquired	Premium	Premium	Premium	CHIEF MEDICAL OFFICER
2024-02-12	Premium	acquired	Premium	Premium	Premium	CHIEF SCIENTIFIC OFFICER
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP AND HEAD OF RESEARCH
2024-01-16	Premium	sold	Premium	Premium	Premium	CHRO
2024-01-16	Premium	sold	Premium	Premium	Premium	COO & CFO
2024-01-16	Premium	sold	Premium	Premium	Premium	GENERAL COUNSEL
2023-12-29	Premium	acquired	Premium	Premium	Premium	COO & CFO
2023-12-29	Premium	sold	Premium	Premium	Premium	COO & CFO
2023-12-27	Premium	gifted	Premium	Premium	Premium	-
2023-12-21	Premium	acquired	Premium	Premium	Premium	-
2023-12-21	Premium	sold	Premium	Premium	Premium	-
2023-12-14	Premium	sold	Premium	Premium	Premium	SVP AND HEAD OF RESEARCH
2023-12-14	Premium	acquired	Premium	Premium	Premium	SVP AND HEAD OF RESEARCH
2023-12-13	Premium	acquired	Premium	Premium	Premium	-

SRRK - Scholar Rock Holding Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for SRRK